{"count":7,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/ad995534-a77f-4cf0-8b8e-e195c3505a2b/","filing_uuid":"ad995534-a77f-4cf0-8b8e-e195c3505a2b","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/ad995534-a77f-4cf0-8b8e-e195c3505a2b/print/","filing_document_content_type":"text/html","income":null,"expenses":"333610.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Iain Mackay Adams","dt_posted":"2026-04-20T12:14:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"20 F Sreet NW","registrant_address_2":"Suite 310 C","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":288373,"url":"https://lda.gov/api/v1/registrants/288373/","house_registrant_id":37093,"name":"THE SOCIETY OF THORACIC SURGEONS","description":"Enhance the ability of cardiothoracic surgeons to provide the highest quality patient care","address_1":"20 F Sreet NW","address_2":"Suite 310 C","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"IAIN MACKAY ADAMS","contact_telephone":"+1 720-937-7277","dt_updated":"2026-07-28T14:56:16.471391-04:00"},"client":{"id":177141,"url":"https://lda.gov/api/v1/clients/177141/","client_id":12,"name":"THE SOCIETY OF THORACIC SURGEONS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-10-20"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Physician Payments: H.R. 7520- Efficiency Adjustment Delay Act; the CY 2026 MPFS introduced a 2.5% reduction in work Relative Value Units (RVUs) for non-time-based procedures with additional reductions scheduled every three years. The Efficiency Adjustment Delay Act would delay the implementation of the policy until 2030 and require CMS to provide a justification and improved implementation report to Congress. Educating members on the need for updates to the physician fee schedule with an annual update based on a portion of the growth in the Medicare Economic Index (MEI). Educating members about the harm caused by CMS reducing the indirect practice expense (PE) allocated per work RVU allocated to facility services to 50% of the amount allocated for non-facility (office-based) services.  Medicaid Cuts: Urging Congress to preserve Medicaids vital role in the healthcare system and explore solutions that maintain access to high-quality care, particularly for underserved communities. Access to Care: H.R. 1509/ S.752- The Accelerating Kids Access to Care Act; would require state Medicaid programs to establish a process through which qualifying out-of-state providers may temporarily treat children without undergoing additional screening requirements. It also requires pass-through pricing models for covered drugs under Medicaid. This became law during this quarter. H.R. 2433- Reducing Medically Unnecessary Delays in Care Act; requires Medicare coverage decisions, including prior authorization requirements and adverse coverage decisions, to be based on written clinical criteria that is developed in consultation with physicians. H.R. 4331- The Access to Claims Data Act; would require the Centers for Medicare & Medicaid Services (CMS) to establish a program that allows clinician-led clinical data registries access to Medicare claims data for research, quality of care measurement, and reporting. Educating CMS about the importance of continuing Coverage with Evidence Development (CED) through the STS/ACC TVT Registry to support the safe and evidence-based expansion of TAVR.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Expanding GME opportunities: H.R. 3890- Resident Physician Shortage Reduction Act; adds 14,000 new residency slots over seven years. Loan Repayment: H.R.2028/ S.942- Resident Education Deferred Interest (REDI) Act; would permit a pause on student loan interest accrual and principal loan repayment for the duration of medical residencies and fellowships.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Lung Cancer: H.R.4417/ S. 2927- Mobile Cancer Screening Act; would establish a competitive grant program through the Health Resources and Services Administration (HRSA) to fund mobile cancer screening units, grants of up to $2 million would help providers acquire vehicles, imaging equipment, and essential software to reach more patients where they live. H.R. 2319/ S.1157- Women in Lung Cancer Research; would provide additional funding for prevention and treatment of lung cancer in women, particularly non-smokers. H.R.1197- PREEMIE Reauthorization Act; would reauthorize through FY29 epidemiological studies, data tracking, and prevention efforts conducted by the Centers for Disease Control and Prevention related to preterm birth. This quarter this became law. NIH Funding: Requesting that Congress fund NIH for FY27 at at least $51.303 billion; an 8.7% increase over the enacted funding level for FY26. CDC Funding: Requesting full funding for CDC's Firearms Violence Research and the Office of Smoking Health.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Workforce: S. 266/ H.R. 929- The Dr. Lorna Breen Healthcare Provider Protection Act; would reauthorize a grant program for healthcare organizations and professional associations for employee education on strategies to reduce burnout, peer-support programming, and mental and behavioral health treatment for five years. Communities with a shortage of health care workers, rural communities, and those experiencing burnout due to administrative burdens, such as lengthy paperwork, will be prioritized. This became law this quarter. H.R. 1585/ S.709- The Conrad State 30 and Physician Access Reauthorization Act; would modify the Conrad 30 Waiver program, which incentivizes qualified foreign physicians to serve in underserved communities. H.R.3178- The Save Health Care Workers Act; would make it a federal crime to assault or intimidate hospital workers. S. 2031- Workforce Mobility Act; would prohibit certain noncompete agreements. H.R. 7961- H-1Bs for the Physicians and Healthcare Workforce Act; would exempt physicians and health professionals from the $100,000 H-1B filing fee imposed by the Department of Homeland Security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Telehealth: H.R. 4204/ S. 1261- CONNECT for Health Act; would permanently remove all geographic restrictions on telehealth services and expand originating sites to the location of the patient, including homes, among other provisions. This quarter a 2 year extension for telehealth flexibilities was signed into law.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R.2414- To amend the Public Health Service Act to reauthorize a military and civilian partnership for trauma readiness grant program (aka Mission Zero); would reauthorize a military and civilian partnership for trauma readiness grant program. Securing Defense funding for Lung Cancer Research. This quarter $20 million was appropriated for the Lung Cancer Research Program via the DoD's Congressionally Directed Medical Research Programs, which had been eliminated in FY25. Educating members about the need for military readiness of surgeons.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/12e75bdc-39a5-417e-8549-cb7b712f69ae/","filing_uuid":"12e75bdc-39a5-417e-8549-cb7b712f69ae","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/12e75bdc-39a5-417e-8549-cb7b712f69ae/print/","filing_document_content_type":"text/html","income":null,"expenses":"700000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Elizabeth Kegler","dt_posted":"2026-04-20T15:55:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Avenue, NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105966,"url":"https://lda.gov/api/v1/registrants/401105966/","house_registrant_id":null,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","description":"Healthcare diagnostics","address_1":"801 Pennsylvania Avenue, NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH KEGLER","contact_telephone":"+1 484-323-1671","dt_updated":"2026-07-29T10:30:26.251926-04:00"},"client":{"id":208991,"url":"https://lda.gov/api/v1/clients/208991/","client_id":12,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to data privacy standards and transparency; and Issues related to right to repair for medical devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review; Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5304 / S. S587 / H. Rept. 119-271 / S. Rept. 117-55 - Labor-HHS-Education Appropriation Act, FY 2026;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/82e28d86-ef96-436b-94df-bdc62fe5ac81/","filing_uuid":"82e28d86-ef96-436b-94df-bdc62fe5ac81","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/82e28d86-ef96-436b-94df-bdc62fe5ac81/print/","filing_document_content_type":"text/html","income":null,"expenses":"1240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-07-20T09:22:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/758ff9aa-d9c6-4a3e-954a-8f506c192fcf/","filing_uuid":"758ff9aa-d9c6-4a3e-954a-8f506c192fcf","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/758ff9aa-d9c6-4a3e-954a-8f506c192fcf/print/","filing_document_content_type":"text/html","income":null,"expenses":"182593.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Iain Mackay Adams","dt_posted":"2026-07-20T12:07:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"20 F Sreet NW","registrant_address_2":"Suite 310 C","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":288373,"url":"https://lda.gov/api/v1/registrants/288373/","house_registrant_id":37093,"name":"THE SOCIETY OF THORACIC SURGEONS","description":"Enhance the ability of cardiothoracic surgeons to provide the highest quality patient care","address_1":"20 F Sreet NW","address_2":"Suite 310 C","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"IAIN MACKAY ADAMS","contact_telephone":"+1 720-937-7277","dt_updated":"2026-07-28T14:56:16.471391-04:00"},"client":{"id":177141,"url":"https://lda.gov/api/v1/clients/177141/","client_id":12,"name":"THE SOCIETY OF THORACIC SURGEONS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-10-20"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Physician Payments: H.R. 8163- The Provider Reimbursement Stability Act; would help stabilize Medicare physician payment by raising the budget neutrality trigger from $20 million to $54 million, tying reimbursement to the Medicare Economic Index, and capping annual reductions at 2.5%. The legislation would also require CMS to use real utilization data and allow later adjustments for new or revised codes. H.R. 7520- Efficiency Adjustment Delay Act; the CY 2026 MPFS introduced a 2.5% reduction in work Relative Value Units (RVUs) for non-time-based procedures with additional reductions scheduled every three years. The Efficiency Adjustment Delay Act would delay the implementation of the policy until 2030 and require CMS to provide a justification and improved implementation report to Congress. Educating members on the need for updates to the physician fee schedule with an annual update based on a portion of the growth in the Medicare Economic Index (MEI). Educating members about the harm caused by CMS reducing the indirect practice expense (PE) allocated per work RVU allocated to facility services to 50% of the amount allocated for non-facility (office-based) services.  Medicaid Cuts: Urging Congress to preserve Medicaids vital role in the healthcare system and explore solutions that maintain access to high-quality care, particularly for underserved communities. Access to Care: H.R. 2433- Reducing Medically Unnecessary Delays in Care Act; requires Medicare coverage decisions, including prior authorization requirements and adverse coverage decisions, to be based on written clinical criteria that is developed in consultation with physicians. H.R. 4331- The Access to Claims Data Act; would require the Centers for Medicare & Medicaid Services (CMS) to establish a program that allows clinician-led clinical data registries access to Medicare claims data for research, quality of care measurement, and reporting. Educating CMS about the importance of continuing Coverage with Evidence Development (CED) through the STS/ACC TVT Registry to support the safe and evidence-based expansion of TAVR. Educating HHS and members on the need to protect the scientific integrity of the U.S. Preventive Services Task Force (USPSTF).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Expanding GME opportunities: H.R. 3890- Resident Physician Shortage Reduction Act; adds 14,000 new residency slots over seven years. Loan Repayment: H.R.2028/ S.942- Resident Education Deferred Interest (REDI) Act; would permit a pause on student loan interest accrual and principal loan repayment for the duration of medical residencies and fellowships.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Lung Cancer: H.R.4417/ S. 2927- Mobile Cancer Screening Act; would establish a competitive grant program through the Health Resources and Services Administration (HRSA) to fund mobile cancer screening units, grants of up to $2 million would help providers acquire vehicles, imaging equipment, and essential software to reach more patients where they live. H.R. 2319/ S.1157- Women in Lung Cancer Research; would provide additional funding for prevention and treatment of lung cancer in women, particularly non-smokers. NIH Funding: Requesting that Congress fund NIH for FY27 at at least $51.303 billion; an 8.7% increase over the enacted funding level for FY26. CDC Funding: Requesting full funding for CDC's Firearms Violence Research and the Office of Smoking Health. OMB Uniform Grant Guidance: Submitted comments urging that scientific merit remain the top priority in funding decisions and that safeguards be added to protect ongoing cardiothoracic research from funding disruptions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Workforce: H.R. 1585/ S.709- The Conrad State 30 and Physician Access Reauthorization Act; would modify the Conrad 30 Waiver program, which incentivizes qualified foreign physicians to serve in underserved communities. H.R.3178- The Save Health Care Workers Act; would make it a federal crime to assault or intimidate hospital workers. S. 2031- Workforce Mobility Act; would prohibit certain noncompete agreements. H.R. 7961- H-1Bs for the Physicians and Healthcare Workforce Act; would exempt physicians and health professionals from the $100,000 H-1B filing fee imposed by the Department of Homeland Security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143513,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"PELTZMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153202,"prefix":"ms","prefix_display":"MS.","first_name":"RACHEL","nickname":null,"middle_name":"CLAIRE","last_name":"POLLOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R.2414- To amend the Public Health Service Act to reauthorize a military and civilian partnership for trauma readiness grant program (aka Mission Zero); would reauthorize a military and civilian partnership for trauma readiness grant program. Securing Defense funding for Lung Cancer Research. Educating members about the need for military readiness of surgeons.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145368,"prefix":"mr","prefix_display":"MR.","first_name":"IAIN","nickname":null,"middle_name":"MACKAY","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152349,"prefix":"ms","prefix_display":"MS.","first_name":"HALEY","nickname":null,"middle_name":null,"last_name":"HOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/799e5a99-25ab-4e63-ab62-1b4c5261b642/","filing_uuid":"799e5a99-25ab-4e63-ab62-1b4c5261b642","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/799e5a99-25ab-4e63-ab62-1b4c5261b642/print/","filing_document_content_type":"text/html","income":null,"expenses":"860000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Elizabeth Kegler","dt_posted":"2026-07-20T16:14:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Avenue, NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105966,"url":"https://lda.gov/api/v1/registrants/401105966/","house_registrant_id":null,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","description":"Healthcare diagnostics","address_1":"801 Pennsylvania Avenue, NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH KEGLER","contact_telephone":"+1 484-323-1671","dt_updated":"2026-07-29T10:30:26.251926-04:00"},"client":{"id":208991,"url":"https://lda.gov/api/v1/clients/208991/","client_id":12,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to the right to repair for medical devices; Issues related to 21 CFR Part 212 requirements good and safe manufacturing or radiopharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review. Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 8646 / H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/fe224026-752b-4216-882e-88cc8518f2ee/","filing_uuid":"fe224026-752b-4216-882e-88cc8518f2ee","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/fe224026-752b-4216-882e-88cc8518f2ee/print/","filing_document_content_type":"text/html","income":null,"expenses":"1790000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-10-19T15:50:22-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Colorectal Cancer Early Detection Act, H.R. 5162, S. 5287. This bill will authorize the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to make grants to States to increase awareness and education for colorectal cancer and improve early detection of colorectal cancer. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, S.2024/H.R.3907. This bill would extend funding for the Marketplace navigator program. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act, H.R.9877, S.5066. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839, S.5052. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. Harley Jacobson Clinical Trial Participant Income Exemption Act, H.R. 4184, S.5127. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. Harley Jacobsen Clinical Trial Participant Income Exemption Act, S.5127, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178, S.4566. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP). Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act, H.R.10068, S.5312. This bill requires CDC to develop a strategy and carry out a specific initiative to prevent and reduce the use of electronic cigarettes and emerging tobacco products among youth and young adults. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC and OSH funding, and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 House and Senate Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars s and cessation therapies as well as language to reduce drug shortages and fully implement FDORA.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 House and Senate Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280, S.3607. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178, S.4566. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. Harley Jacobsen Clinical Trial Participant Income Exemption Act, S.5127, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Indian Health Services. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true},{"lobbyist":{"id":155486,"prefix":null,"prefix_display":null,"first_name":"HARLEY","nickname":null,"middle_name":null,"last_name":"ADSIT","suffix":null,"suffix_display":null},"covered_position":"Press Assistant and Press Secretary, Committee on Education and Labor Minority Staff (2021); Communications Director, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1) (2021-2026); Deputy Chief, U.S. Rep. Earl L. \"Buddy\" Carter (R-GA-1).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cc13e5b6-b8c1-4187-a830-d1977f4fde8e/","filing_uuid":"cc13e5b6-b8c1-4187-a830-d1977f4fde8e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/cc13e5b6-b8c1-4187-a830-d1977f4fde8e/print/","filing_document_content_type":"text/html","income":null,"expenses":"510000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Elizabeth Kegler","dt_posted":"2026-10-20T17:22:44-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Avenue, NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105966,"url":"https://lda.gov/api/v1/registrants/401105966/","house_registrant_id":null,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","description":"Healthcare diagnostics","address_1":"801 Pennsylvania Avenue, NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH KEGLER","contact_telephone":"+1 484-323-1671","dt_updated":"2026-07-29T10:30:26.251926-04:00"},"client":{"id":208991,"url":"https://lda.gov/api/v1/clients/208991/","client_id":12,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Artificial Intelligence, cybersecurity and data for medical devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to medical supply chain resiliency and procurement; and Issues related to access to artificial intelligence models.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to medical supply chain resiliency and procurement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 - issues related to funding for the Food & Drug Administration; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027 - issues related to artificial intelligence and funding for Department of Human Services & National Institutes of Health.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}